Drug maker Cipla has announced its awareness campaign — InhalersHainSahi — to dispel myths and fears against using inhalers to cure asthma in India. Medical practitioners expressed their enthusiasm and support for the campaign as stigma against inhalers is very much present in the country. Educating the patients is essential in order for them to follow the prescription of doctors, say medical practitioners. The company said in a media statement that the campaign is a positive step towards eliminating the stigma surrounding the use of inhalers and would help more people to adopt this effective method to treat asthma and other diseases. Cipla is currently the market leader in the respiratory segment, particularly inhalers, in India.